A critical discovery in cancer study is arising with the use of VHH fragments to restore dysfunctional p53. This crucial tumor protector protein is frequently disabled in many kinds of cancer, resulting uncontrolled https://thefairlist.com/story12226791/mini-antibodies-reactivate-p53-the-promising-pathway-for-cancer-therapy